The p53 Colorectal Cancer Trial
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
Single center, open labeled, phase 2 clinical trial, where patients with metastatic colorectal cancer are selected for treatment with dose dense Cyclophosphamide every second week based on TP53 mutation status; i.e. only patients with TP53 mutated tumors may be included in the treatment arm.
创建时间：
2017-05-15
相关数据集
暂无相关数据集
